{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:19Z","timestamp":1707524239471},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,28]]},"DOI":"10.7759\/cureus.14159","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T16:39:51Z","timestamp":1616949591000},"source":"Crossref","is-referenced-by-count":0,"title":["Squamous Cell Carcinoma of the Lung in McCune-Albright Syndrome"],"prefix":"10.7759","author":[{"given":"Vinai Y","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Tvedten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthanna","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright syndrome","volume":"3","author":"Dumitrescu CE","year":"2008","unstructured":"Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis. 2008, 3:12. 10.1186\/1750-1172-3-12","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2014.535","article-title":"Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms. GNAS-activating mutations in pancreatic carcinogenesis","volume":"149","author":"Parvanescu A","year":"2014","unstructured":"Parvanescu A, Cros J, Ronot M, et al.. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms. GNAS-activating mutations in pancreatic carcinogenesis. JAMA Surg. 2014, 149:858-62. 10.1001\/jamasurg.2014.535","journal-title":"JAMA Surg"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0122-3","article-title":"Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism","volume":"20","author":"Patra KC","year":"2018","unstructured":"Patra KC, Kato Y, Mizukami Y, et al.. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol. 2018, 20:811-822.","journal-title":"Nat Cell Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018102","article-title":"McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report","volume":"98","author":"Gaujoux S","year":"2019","unstructured":"Gaujoux S, Pasmant E, Silve C, et al.. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report. Medicine (Baltimore). 2019, 98:e18102. 10.1097\/MD.0000000000018102","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1 \u200as activation","volume":"41","author":"Boyce AM","year":"2020","unstructured":"Boyce AM, Collins MT. Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1 \u200as activation. Endocr Rev. 2020, 41:345-370. 10.1210\/endrev\/bnz011","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1986.tb01261.x","article-title":"The McCune-Albright syndrome: a lethal gene surviving by mosaicism","volume":"29","author":"Happle R","year":"1986","unstructured":"Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986, 29:321-4. 10.1111\/j.1399-0004.1986.tb01261.x","journal-title":"Clin Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce AM","year":"2012","unstructured":"Boyce AM, Chong WH, Yao J, et al.. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012, 27:1462-70. 10.1002\/jbmr.1603","journal-title":"J Bone Miner Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02543","article-title":"Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates","volume":"104","author":"Majoor BCJ","year":"2019","unstructured":"Majoor BCJ, Papapoulos SE, Dijkstra PDS, Fiocco M, Hamdy NAT, Appelman-Dijkstra NM. Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates. J Clin Endocrinol Metab. 2019, 104:6069-6078. 10.1210\/jc.2018-02543","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-016-0317-0","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: clinical and translational perspectives","volume":"14","author":"Robinson C","year":"2016","unstructured":"Robinson C, Collins MT, Boyce AM. Fibrous dysplasia\/McCune-Albright syndrome: clinical and translational perspectives. Curr Osteoporos Rep. 2016, 14:178-86. 10.1007\/s11914-016-0317-0","journal-title":"Curr Osteoporos Rep"},{"key":"ref10","unstructured":"Hypercalcemia of malignancy. mechanisms. (2020). https:\/\/www.uptodate.com\/contents\/hypercalcemia-of-malignancy-mechanisms."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090981","article-title":"PTH-related peptide (PTHrP) in hypercalcemia","volume":"19","author":"Mundy GR","year":"2008","unstructured":"Mundy GR, Edwards JR. PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol. 2008, 19:672-5. 10.1681\/ASN.2007090981","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23","volume":"4","author":"Imel EA","year":"2007","unstructured":"Imel EA, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev. 2007, 4:434-439.","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53437-squamous-cell-carcinoma-of-the-lung-in-mccune-albright-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:32Z","timestamp":1707506792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53437-squamous-cell-carcinoma-of-the-lung-in-mccune-albright-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.14159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,28]]}}}